naphthalene has been researched along with Neoplasms in 19 studies
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regarding cancer risks, benzo[a]pyrene levels in all the groups indicated a potential risk." | 1.91 | Risk characterization of human exposure to polycyclic aromatic hydrocarbons in vulnerable groups. ( Barbosa, F; Campíglia, AD; Cruz, JC; Domingo, JL; Palir, N; Rocha, BA; Souza, MCO, 2023) |
| "All 32 conjugates show anticancer potential, with some of them exhibiting particularly high activity (0." | 1.37 | Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability. ( Bag, I; Juvekar, A; Kamal, A; Kumar, GB; Pal-Bhadra, M; Pushpavalli, SN; Ramaiah, MJ; Reddy, MK; Reddy, VS; Sen, S; Srikanth, YV; Zingde, SM, 2011) |
| " Probabilities are assigned to alternative model components, including the determination of human carcinogenicity, mode of action, the dosimetry measure for exposure, the mathematical form of the dose-response relationship, the experimental data set(s) used to fit the relationship, and the formula used for interspecies extrapolation." | 1.35 | Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment. ( Small, MJ, 2008) |
| "Total mortality and all-cancer mortality were similar to expected in both males and females." | 1.32 | Cohort mortality study of capacitor manufacturing workers, 1944-2000. ( D'Aloisio, A; Dimos, J; Freels, S; Mallin, K; McCann, K; Persky, V; Piorkowski, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Souza, MCO | 1 |
| Rocha, BA | 1 |
| Cruz, JC | 1 |
| Palir, N | 1 |
| Campíglia, AD | 1 |
| Domingo, JL | 1 |
| Barbosa, F | 1 |
| Maeda, K | 1 |
| Mochizuki, S | 1 |
| Sanada, Y | 1 |
| Sakurai, K | 1 |
| Small, MJ | 1 |
| Reddy, GR | 1 |
| Kuo, CC | 1 |
| Tan, UK | 1 |
| Coumar, MS | 1 |
| Chang, CY | 1 |
| Chiang, YK | 1 |
| Lai, MJ | 1 |
| Yeh, JY | 1 |
| Wu, SY | 1 |
| Chang, JY | 1 |
| Liou, JP | 1 |
| Hsieh, HP | 1 |
| Dias, DA | 1 |
| Silva, CA | 1 |
| Urban, S | 1 |
| Zahid, M | 1 |
| Saeed, M | 2 |
| Rogan, EG | 1 |
| Cavalieri, EL | 1 |
| Kamal, A | 1 |
| Reddy, MK | 1 |
| Ramaiah, MJ | 1 |
| Srikanth, YV | 1 |
| Reddy, VS | 1 |
| Kumar, GB | 1 |
| Pushpavalli, SN | 1 |
| Bag, I | 1 |
| Juvekar, A | 1 |
| Sen, S | 1 |
| Zingde, SM | 1 |
| Pal-Bhadra, M | 1 |
| Preuss, R | 1 |
| Angerer, J | 1 |
| Drexler, H | 1 |
| ROSINA, G | 1 |
| VIDEBAEK, A | 1 |
| KAAE, S | 2 |
| VIDEBAEK, AA | 1 |
| UEBELIN, F | 1 |
| PLETSCHER, A | 1 |
| KUHL, I | 1 |
| PEARSON, AE | 1 |
| POWELL, AK | 1 |
| MELANDRI, F | 1 |
| PATRONCINI, F | 1 |
| FRIEDMANN, E | 1 |
| BAILEY, NT | 1 |
| MULAY, AS | 1 |
| FIRMINGER, HI | 1 |
| Mallin, K | 1 |
| McCann, K | 1 |
| D'Aloisio, A | 1 |
| Freels, S | 1 |
| Piorkowski, J | 1 |
| Dimos, J | 1 |
| Persky, V | 1 |
| Higginbotham, S | 1 |
| Rogan, E | 1 |
| Cavalieri, E | 1 |
1 review available for naphthalene and Neoplasms
| Article | Year |
|---|---|
Naphthalene--an environmental and occupational toxicant.
Topics: Environmental Exposure; Environmental Monitoring; Humans; Knowledge; Naphthalenes; Neoplasms; Occupa | 2003 |
18 other studies available for naphthalene and Neoplasms
| Article | Year |
|---|---|
Risk characterization of human exposure to polycyclic aromatic hydrocarbons in vulnerable groups.
Topics: Benzo(a)pyrene; Carcinogenesis; Carcinogens; Child; Environmental Monitoring; Environmental Pollutan | 2023 |
Naphthalene-hydrophobized β-1,3-glucan nanogel for doxorubicin delivery to immunocytes.
Topics: Antigen-Presenting Cells; Antineoplastic Agents; beta-Glucans; Doxorubicin; Drug Delivery Systems; H | 2014 |
Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment.
Topics: DNA Damage; Dose-Response Relationship, Drug; Formaldehyde; Humans; Inhalation Exposure; Likelihood | 2008 |
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
Topics: Anisoles; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screeni | 2008 |
Naphthalene aglycones and glycosides from the Australian medicinal plant, Dianella callicarpa.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Cell Line, Tumo | 2009 |
Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease.
Topics: Aminobutyrates; Animals; Benzene; Catechols; Cattle; Cell Transformation, Neoplastic; Chromatography | 2010 |
Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability.
Topics: Antineoplastic Agents; Apoptosis; Benzodiazepines; Caspase 9; Cell Line, Tumor; Drug Design; Humans; | 2011 |
[Sarcoma of the bladder in chemical workers in amine products].
Topics: Amines; Humans; Naphthalenes; Neoplasms; Sarcoma; Urinary Bladder Neoplasms | 1952 |
Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.
Topics: Hodgkin Disease; Hydrocarbons, Aromatic; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard | 1954 |
[Beta-Naphthyl-di-chlorethylamine therapy of malignant conditions, especially Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard Compounds | 1954 |
[Etiology and prophylaxis of occupational tumors in dye workers].
Topics: Benzidines; Humans; Naphthalenes; Neoplasms; Occupational Diseases; Urinary Bladder Neoplasms | 1954 |
[Allergic-hyperergic symptoms in mice after beta-naphthalamine administration, manifested by periarteritis nodosa, activation of the reticuloendothelial system, plasma cell hyperplasia and paraproteinosis of various organs].
Topics: Animals; Hyperplasia; Hypersensitivity; Immune System Diseases; Mice; Mononuclear Phagocyte System; | 1956 |
The inhibitory effect of acenaphthenequinone-bisulphite upon tumour growth in mice.
Topics: Acenaphthenes; Animals; Mice; Naphthalenes; Neoplasms; Neoplasms, Experimental; Quinones; Sulfites | 1955 |
[Results of prolonged treatment with chloronaphthyne in a case of reticulum cell sarcoma; preliminary note].
Topics: Abdomen; Abdominal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamin | 1955 |
Action of I:4-naphthohydroquinone-diphosphate and its 2-methyl derivative on irradiated and non-irradiated rats with Jensen sarcoma.
Topics: Animals; Naphthalenes; Neoplasms; Rats; Sarcoma; Sarcoma, Experimental | 1950 |
Liver tumors induced in rats by p-dimethylaminobenzene-1-azo-1-naphthalene compared with tumors induced by p-dimethylaminoazobenzene.
Topics: Animals; Liver Neoplasms; Naphthalenes; Neoplasms; p-Dimethylaminoazobenzene; Rats | 1952 |
Cohort mortality study of capacitor manufacturing workers, 1944-2000.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cohort Studies; Female; Humans; Illinois; Industry; | 2004 |
Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene.
Topics: Adenine; Carcinogens; DNA Adducts; Guanine; Kinetics; Molecular Structure; Naphthalenes; Naphthols; | 2007 |